Skip to content

 The Lancet Rheumatology Publishes pilot clinical data showing promising efficacy and safety profile for e-mmunotherapy in Rheumatoid Arthritis patients. Fifty-three percent (53%) of patients receiving e-mmunotherapy, using the Nēsos earbud shaped neural interface, had meaningful reduction in disease activity after 3 months, while 37% of patients achieved low disease activity and 23% of patients achieved…

Read More